Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-10-22-Speech-4-015"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2009-10-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Problem of limited access of developing countries to some vaccines (debate)2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20091022.4.4-015"2
lpv:hasSubsequent	lp_eu:2009-10-22-Speech-4-0162
lpv:speaker	lp:Marisa Matias2
lpv:spokenAs	substitute; Delegation for relations with South Africa (2009-09-16--2014-06-30)3 unknown; Bloco de Esquerda (2009-07-14--2014-06-30)3 member; EUL/NGL (2009-07-14--2012-01-22)3 substitute; Delegation for relations with the Palestinian Legislative Council (2009-09-16--2014-06-30)3 vice-chair; Delegation for relations with the Mashreq countries (2009-09-17--2014-06-30)3 member; ITRE (2009-07-16--2012-01-18)3 substitute; ENVI (2009-07-16--2012-01-18)3
lpv:translated text	"Mr President, Commissioner, I would first of all like to stress the importance of the question that was asked by Mr Goerens, which is a matter of basic justice. We are all perfectly aware that, in an influenza A pandemic situation, it would be southern countries that bear the brunt of this problem and the consequences of the spread of the virus, and not northern countries. Every year, we sit idly by as thousands of citizens die as a result of pandemics that have already been eradicated or are treatable in northern countries, and there is a very long list: malaria, dengue fever, yellow fever, tuberculosis. The list is endless, yet we watch and do nothing about this problem. In fact, we use the southern countries as suppliers of samples of new strains of viruses, free of charge, so we can improve treatment in northern countries, but we do not provide an effective response to these problems. I would therefore just like to add some more questions to those that were asked. Do we actually want to treat this problem as a public health problem or as a business? If we want to treat it as a public health problem, then we have to ensure equal access to treatment in all regions of the world and we therefore have to be more effective in our efforts. That being said, I would like to ask, and I hope that it is not the case, if we are waiting for there finally to be surplus stocks of vaccines in Europe or for the side effects to prove too harmful before we show our generosity and suddenly start sending the necessary vaccines to southern countries. Lastly, I would just like to ask if the European Union, if we Europeans, and if the Commission feels comfortable with a system or with a model whereby northern countries deal with pandemics by means of a prevention model and southern countries are given palliatives or simply leftovers."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph